Detalles de la búsqueda
1.
Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
Rheumatology (Oxford)
; 54(7): 1210-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25541333
2.
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis.
Clin Rheumatol
; 43(5): 1591-1604, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472528
3.
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies.
ACR Open Rheumatol
; 5(4): 227-240, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880890
4.
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial.
RMD Open
; 8(2)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863864
5.
Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study.
Am J Clin Dermatol
; 20(6): 873-880, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31612380
6.
Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.
Arthritis Rheum
; 59(7): 952-60, 2008 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18576290
7.
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.
J Rheumatol
; 31(7): 1356-61, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15229957
Resultados
1 -
7
de 7
1
Próxima >
>>